F 0695
Provide safe and appropriate respiratory care for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
Based on observation, interview, and record review the facility failed to ensure respiratory care services
were provided for oxygen administration for 1 of 3 Residents, Resident #5, reviewed for respiratory
services.
Residents Affected - Few
Findings include:
Record review of Resident #5's clinical record documented the resident was admitted with diagnosis that
included: anemia, atherosclerosis heart disease, pulmonary hypertension, and chronic obstructive
pulmonary disease.
Review of Resident #5's physician orders dated 3/3/2025 read, Oxygen at 4LPM [liters per minute] via NC
[nasal cannula] every shift.
Review of Resident #5's care plan dated 2/6/2025 read, Focus: The resident has oxygen therapy r/t [related
to] COPD [chronic obstructive pulmonary disease]. Interventions/Tasks: Give medications as ordered by
physician.
During an observation on 3/3/2025 at 10:08 AM of Resident #5, the resident was sitting at bedside. Oxygen
was being administered at 3 liters per minute via nasal cannula. (Photograph evidence obtained).
During an interview on 3/3/2025 at 1:16 PM Resident #5 stated, I do not change the settings [oxygen].,
Normally I am on 4 liters when I am up walking around and 3 liters when I'm resting.
During an observation on 3/3/2025 at 1:16 PM with Staff A, Registered Nurse (RN) Resident #5 was
observed sitting at bedside with oxygen administered at 3 liters per minute via nasal cannula.
During an interview on 3/3/2025 at 1:16 PM Staff A, RN verified the physician orders were for oxygen to be
administered at 4 liters per minute via nasal cannula.
During an interview on 3/3/2025 at 1:30 PM the Director of Nursing (DON) stated, The physician orders
have to be followed, and the rate should be 4 liters a minute.
Review of the policy and procedure titled Oxygen Therapy dated 1/22/2025 read, Policy: III. A. 1. Specific
delivery device, liter flow or concentration .Procedure: IV. A. Set up oxygen utilizing appropriate delivery
device according to physician's order, or according to protocol.
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
106105
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106105
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/05/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Skytop View Rehabilitation Center
2145 North Don Wickham Drive
Clermont, FL 34711
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
Based on record review and interview, the facility failed to ensure a rationale was in the medical record for
psychotropic PRN (pro re nata/as needed) medications being prescribed for greater than 14 days for 1 of 5
residents, Resident #84, reviewed for unnecessary medications.
Findings include:
Review of the pharmacist's consultation report, dated 2/17/2025, read [Resident #84's Name] has a PRN
order for a sedative/hypnotic, without a stop date: Zolpidem 10mg [milligrams] q [every] HS [hour of sleep]
PRN for insomnia. Recommendation: Please discontinue PRN Zolpidem, or a stop date that is less than 14
days from initiation. If the medication cannot be discontinued at this time, document the indication for use,
the intended duration of therapy, and the rationale for the extended time period.
Review of Resident #84's physician's orders dated 2/17/25 read Zolpidem Tartrate Oral Tablet 10MG
[milligrams] (Zolpidem Tartrate) *Controlled Drug* Give 1 tablet by mouth every 24 hours as needed for
Difficulty Sleeping for 30 days. The physician's order did not contain documented rationale for prescribing
the medication for more than 14 days.
Review of a physician's visit encounter note, dated 2/17/2025, read Zolpidem Tartrate 10mg 1 tab [tablet]
q24 [every 24] hours PRN x 30 days (end 3/19/25).
During an interview on 3/4/2025 beginning at 12:04 PM, the Director of Nursing stated she was unable to
answer whether or not the physician had documented in Resident #84's clinical record the rationale for
prescribing hypnotic medication for more than 14 days.
Review of the policy titled Drug Regimen Review, last reviewed 1/22/2025, read, I. PURPOSE: This
department process explains how this facility follows State and Federal Regulations, by having the
Consultant Pharmacist review each resident's clinical chart monthly. Apparent irregularities will be reported
in writing to the Director of Nursing, Medical Director, Attending Physician, Provider and Administrator. The
facility will review and follow through on the Consultant Pharmacist's recommendations to ensure all
residents maintain the highest practicable level of functioning .D. Follow up on Consultant Pharmacist
Recommendations: .b. Clinical justification will be documented in the chart if a recommendation is declined
by the physician/provider.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
106105
If continuation sheet
Page 2 of 3
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
106105
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/05/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Skytop View Rehabilitation Center
2145 North Don Wickham Drive
Clermont, FL 34711
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observation, interview, and record review, the facility failed to secure medications for 1 of 3 wings,
the south.
Findings included:
During an observation on 3/3/2025 at 10:08 AM of Resident #5's room there was one bottle of Saline Nasal
Mist and one bottle of normal saline eye solution on the bedside table unsecured. (Photograph evidence
obtained).
During an observation on 3/3/2025 at 12:18 PM of Resident #5's room there was one bottle of Saline Nasal
Mist and one bottle of normal saline eye solution on the bedside table unsecured.
During an interview on 3/3/2025 at 12:22 PM Resident #5 stated, My wife brought them to me and I use
them as needed at least daily.
During an interview on 3/3/2025 at 12:30 PM Staff A, Registered Nurse (RN) verified the Saline Nasal Mist
and bottle of normal saline eye solution medications unsecured at Resident #5's bedside. Staff A, RN
stated, Medication cannot be kept at the bedside, all medications have to be secured.
During an interview on 3/3/2025 at 1:16 PM the Director of Nursing stated, Medications cannot be at the
bedside unsecured.
Review of the policy and procedure titled Medication Storage dated 1/22/2025 read, This department
process explains how medications and biologicals are stored safely, securely, and properly . B. Only
licensed nurses, pharmacy personnel, and those lawfully authorized to administer medications are
permitted to access medications. Medication rooms, carts, and medication supplies are locked when not
attended to by persons with authorized access.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
106105
If continuation sheet
Page 3 of 3